Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, Valesca Bukur, Stefan Stevanović, Cecile Gouttefangeas, Michael Platten, Ghazaleh Tabatabai, Valerie Dutoit, Sjoerd H. Burg, Per thor Straten, Francisco Martinez-Ricarte, Berta Ponsati, Hideho Okada, Ulrik Lassen, Arie Admon, Christian H. Ottensmeier, Alexander Ulges, Sebastian Kreiter, Andreas Deimling, Marco Skardelly, Denis Migliorini, Judith R. Kroep, Manja Idorn, Jordi Rodon, Jordi Piro, Hans S. Poulsen, Bracha Shraibman, Katy McCann, Regina Mendrzyk, Martin Lower, Monika Stieglbauer, Cedrik M. Britten, David Capper, Marij J. P. Welters, Juan Sahuquillo, Katharina Kiesel, Evelyna Derhovanessian, Elisa Rusch, Lukas Bunse, Colette Song, Sandra Heesch, Claudia Wagner, Alexandra Kemmer-Bruck, Jorg Ludwig, John C. Castle, Oliver Schoor, Arbel D. Tadmor, Edward Green, Jens Fritsche, Miriam Meyer, Nina Pawlowski, Sonja Dorner, Franziska Hoffgaard, Bernhard Rossler, Dominik Maurer, Toni Weinschenk, Carsten Reinhardt, Christoph Huber, Hans-Georg Rammensee, Harpreet Singh-Jasuja, Ugur Sahin, Pierre-Yves Dietrich and Wolfgang Wick ()
Additional contact information
Norbert Hilf: Immatics Biotechnologies GmbH
Sabrina Kuttruff-Coqui: Immatics Biotechnologies GmbH
Katrin Frenzel: BioNTech AG
Valesca Bukur: BioNTech AG
Stefan Stevanović: Eberhard Karls Universität Tübingen
Cecile Gouttefangeas: Eberhard Karls Universität Tübingen
Michael Platten: University Hospital Heidelberg
Ghazaleh Tabatabai: Eberhard Karls Universität Tübingen
Valerie Dutoit: Geneva University Hospital
Sjoerd H. Burg: CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program
Per thor Straten: CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program
Francisco Martinez-Ricarte: Vall d’Hebron University Hospital
Berta Ponsati: BCN Peptides SA
Hideho Okada: University of California, San Francisco
Ulrik Lassen: Ringhospitalet
Arie Admon: Technion - Israel Institute of Technology
Christian H. Ottensmeier: University of Southampton
Alexander Ulges: Immatics Biotechnologies GmbH
Sebastian Kreiter: BioNTech AG
Andreas Deimling: University Hospital Heidelberg
Marco Skardelly: University Hospital Tübingen
Denis Migliorini: Geneva University Hospital
Judith R. Kroep: Leiden University Medical Center
Manja Idorn: University Hospital Herlev
Jordi Rodon: Vall d’Hebron University Hospital
Jordi Piro: BCN Peptides SA
Hans S. Poulsen: Ringhospitalet
Bracha Shraibman: Technion - Israel Institute of Technology
Katy McCann: University of Southampton
Regina Mendrzyk: Immatics Biotechnologies GmbH
Martin Lower: BioNTech AG
Monika Stieglbauer: Eberhard Karls Universität Tübingen
Cedrik M. Britten: BioNTech AG
David Capper: University Hospital Heidelberg
Marij J. P. Welters: CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program
Juan Sahuquillo: Vall d’Hebron University Hospital
Katharina Kiesel: Immatics Biotechnologies GmbH
Evelyna Derhovanessian: BioNTech AG
Elisa Rusch: Eberhard Karls Universität Tübingen
Lukas Bunse: University Hospital Heidelberg
Colette Song: Immatics Biotechnologies GmbH
Sandra Heesch: BioNTech AG
Claudia Wagner: Immatics Biotechnologies GmbH
Alexandra Kemmer-Bruck: BioNTech AG
Jorg Ludwig: Immatics Biotechnologies GmbH
John C. Castle: BioNTech AG
Oliver Schoor: Immatics Biotechnologies GmbH
Arbel D. Tadmor: TRON GmbH - Translational Oncology at the University Medical Center of Johannes Gutenberg University
Edward Green: German Cancer Consortium (DKTK), German Cancer Research Center
Jens Fritsche: Immatics Biotechnologies GmbH
Miriam Meyer: Immatics Biotechnologies GmbH
Nina Pawlowski: Immatics Biotechnologies GmbH
Sonja Dorner: Immatics Biotechnologies GmbH
Franziska Hoffgaard: Immatics Biotechnologies GmbH
Bernhard Rossler: Immatics Biotechnologies GmbH
Dominik Maurer: Immatics Biotechnologies GmbH
Toni Weinschenk: Immatics Biotechnologies GmbH
Carsten Reinhardt: Immatics Biotechnologies GmbH
Christoph Huber: BioNTech AG
Hans-Georg Rammensee: Eberhard Karls Universität Tübingen
Harpreet Singh-Jasuja: Immatics Biotechnologies GmbH
Ugur Sahin: BioNTech AG
Pierre-Yves Dietrich: Geneva University Hospital
Wolfgang Wick: University Hospital Heidelberg

Nature, 2019, vol. 566, issue 7745, E13-E13

Abstract: The additional author support information was erroneously omitted from the Supplementary Information. This has been corrected online.

Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.nature.com/articles/s41586-019-0959-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:566:y:2019:i:7745:d:10.1038_s41586-019-0959-z

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-019-0959-z

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().